Janssen COVID-19 vaccine (Ad26.COV2.S)

Ad26.COV2.S · Janssen Vaccines & Prevention B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Janssen COVID-19 vaccine (Ad26.COV2.S), covering 2024-05-23 to 2024-10-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults [Phase 3]